- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07720505
COLOFLOW: Laser Speckle Contrast Imaging Versus Near-infrared Fluorescence Imaging With Indocyanine Green (COLOFLOW)
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Study Title: COLOFLOW: Quantified ICG Fluorescence versus Laser Speckle Contrast Imaging (LSCI) for Perfusion Assessment in Colorectal Surgery.
Background Anastomotic leakage is a serious complication after colorectal surgery, occurring in approximately 10-15% of patients and contributing substantially to postoperative morbidity and mortality. Surgeons increasingly use indocyanine green (ICG) fluorescence imaging to assess bowel perfusion during surgery, but interpretation remains largely subjective and the technique has limitations, including dye dependency and difficulties with repeated measurements. Laser Speckle Contrast Imaging (LSCI) is a dye-free, real-time imaging technique that provides objective perfusion maps and may overcome several of these limitations.
Aim The primary aim of the study is to determine how well subjective intraoperative ICG fluorescence assessment agrees with LSCI perfusion imaging when evaluating bowel perfusion at the planned anastomotic site during colorectal surgery.
Secondary aims are:
To evaluate the spatial agreement between postoperative quantitative ICG analysis and LSCI perfusion boundaries.
To assess the feasibility of using the PerfusiX-IGS LSCI system during open colorectal surgery.
To record clinical outcomes, including anastomotic leakage rates.
Study Design COLOFLOW is a prospective, single-centre, observational study conducted at the Leiden University Medical Centre (LUMC). No randomization, blinding, or intervention is performed. LSCI measurements are recorded for research purposes only and do not influence surgical decision-making.
Participants The study includes approximately 30 adult patients undergoing elective colon or rectal resection with creation of a primary anastomosis. This population corresponds to patients enrolled in the ongoing QUANTICOLON study.
Inclusion Criteria
Age ≥18 years. Elective colorectal resection with primary anastomosis. Ability to provide informed consent.
Exclusion Criteria
Palliative surgery. Poor intraoperative visualization. Conditions that substantially interfere with perfusion assessment.
Methods
During surgery:
The surgeon identifies the planned bowel transection site under white light. The bowel is exteriorized for imaging. The PerfusiX-IGS LSCI system records a perfusion map. Standard-of-care ICG fluorescence imaging is then performed and interpreted subjectively by the surgeon.
After surgery, ICG recordings are quantitatively analysed using dedicated software to derive perfusion parameters such as:
Time to fluorescence onset (T0) Time to peak intensity (Tmax) Maximum intensity (Imax) Maximum normalized slope Outflow area-under-the-curve measurements
A custom Python-based analysis is used to compare the location of perfusion boundaries identified by both imaging techniques.
Outcomes Primary Endpoint
Agreement between subjective ICG interpretation and LSCI perfusion mapping, assessed by:
Categorical agreement (adequate vs. inadequate perfusion). Spatial agreement between perfusion boundaries identified by both modalities.
Secondary Endpoints
Distance between quantitative ICG and LSCI perfusion boundaries. Feasibility and usability of the PerfusiX-IGS system. Success rate of obtaining calibrated image documentation. Thirty-day postoperative outcomes, including complications and anastomotic leakage.
Statistical Analysis Categorical agreement will be evaluated using Cohen's kappa coefficient, while spatial agreement will be assessed with Bland-Altman analysis. Secondary analyses will explore whether quantitative ICG measurements provide better agreement with LSCI than subjective assessment alone.
Ethical Considerations The study is classified as non-WMO (non-Medical Research Involving Human Subjects Act) because it introduces no intervention beyond standard care. LSCI is non-contact, non-invasive, and does not influence treatment decisions. Risks to participants are minimal and primarily related to the storage and handling of anonymized imaging data.
Conclusion COLOFLOW investigates whether objective, dye-free LSCI can serve as a reliable reference method for bowel perfusion assessment during colorectal surgery and whether postoperative quantitative analysis of ICG fluorescence can improve upon the current subjective interpretation of ICG imaging. The study aims to support the development of more standardized and objective perfusion assessment strategies that may ultimately help reduce anastomotic leakage.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Indy Planting, MD
- Telefonnummer: +31614524783
- E-Mail: i.planting@lumc.nl
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Adults ≥18 years.
- Undergoing elective colon resection with primary anastomosis.
- Able to provide consent for postoperative analysis of intraoperative imaging
Exclusion Criteria:
- Palliative surgery.
- Factors that severely limit intraoperative visualization (per investigator judgement).
Conditions interfering with perfusion assessment (e.g., severe peripheral vascular compromise).
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Agreement ICG vs LSCI
Zeitfenster: Periprocedural and day 0 (day of surgery)
|
the agreement between subjective ICG fluorescence assessment and LSCI perfusion imaging at the planned anastomotic site during colorectal surgery.
This agreement will be evaluated in two ways: (1) categorical agreement, determining whether both techniques classify perfusion as adequate or inadequate, and (2) spatial agreement, assessing how closely the perfusion boundary identified by the surgeon using ICG corresponds to the perfusion boundary detected by LSCI.
|
Periprocedural and day 0 (day of surgery)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Spatial Agreement
Zeitfenster: From surgery untill 30 days follow up
|
Spatial distance (in millimetres) between the quantitative ICG perfusion boundary and the LSCI perfusion boundary
|
From surgery untill 30 days follow up
|
|
Feasibility Laser Speckle Device
Zeitfenster: Peri-procedural (day 0)
|
the feasibility and usability of the PerfusiX-IGS LSCI system Unit of Measure: Successful acquisitions (%) Acquisition time (seconds) Technical failures (%) |
Peri-procedural (day 0)
|
|
30-day postoperative clinical outcomes
Zeitfenster: Day 0 untill 30-days post operatively
|
Clinical outcomes and the occurrence of anastomotic leakage.
The proportion of patients experiencing any complication and the distribution of Clavien-Dindo grades will be recorded.
Incidence of anastomotic leakage within 30 days after surgery, defined according to standard clinical and/or radiological criteria as applied in routine clinical practice.
The proportion of patients diagnosed with anastomotic leakage will be recorded.
|
Day 0 untill 30-days post operatively
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- De Nardi P, Elmore U, Maggi G, Maggiore R, Boni L, Cassinotti E, Fumagalli U, Gardani M, De Pascale S, Parise P, Vignali A, Rosati R. Intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter randomized controlled trial. Surg Endosc. 2020 Jan;34(1):53-60. doi: 10.1007/s00464-019-06730-0. Epub 2019 Mar 21.
- Wildeboer A, Heeman W, van der Bilt A, Hoff C, Calon J, Boerma EC, Al-Taher M, Bouvy N. Laparoscopic Laser Speckle Contrast Imaging Can Visualize Anastomotic Perfusion: A Demonstration in a Porcine Model. Life (Basel). 2022 Aug 16;12(8):1251. doi: 10.3390/life12081251.
- Heeman W, Wildeboer ACL, Al-Taher M, Calon JEM, Stassen LPS, Diana M, Derikx JPM, van Dam GM, Boerma EC, Bouvy ND. Experimental evaluation of laparoscopic laser speckle contrast imaging to visualize perfusion deficits during intestinal surgery. Surg Endosc. 2023 Feb;37(2):950-957. doi: 10.1007/s00464-022-09536-9. Epub 2022 Sep 6.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Postoperative Komplikationen
- Pathologische Prozesse
- Neubildungen nach Standort
- Neubildungen
- Darmerkrankungen
- Gastrointestinale Neubildungen
- Neoplasmen des Verdauungssystems
- Erkrankungen des Verdauungssystems
- Magen-Darm-Erkrankungen
- Kolorektale Neubildungen
- Darmtumoren
- Darmerkrankungen
- Pathologische Zustände, Anzeichen und Symptome
- Rektale Neoplasien
- Darmneoplasmen
- Anastomoseninsuffizienz
- Rektale Erkrankungen
- Untersuchungstechniken
- Diagnosetechniken und Verfahren
- Diagnose
- Diagnostische Bildgebung
- Optische Bildgebung
- Laser-Speckle-Kontrastbildgebung
Andere Studien-ID-Nummern
- COLOFLOW
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Darmkrebs
-
Universitätsmedizin MannheimBeendetColo-Colon Anastomosen | Ileokolonische AnastomosenDeutschland
-
Universitätsklinikum Hamburg-EppendorfBeendetWundendoskopisch, Dickdarm | Nach Polypenresektion, ColonDeutschland
-
Nihon Pharmaceutical Co., LtdAbgeschlossenMagenkrebs | Magenadenom | Colon Nos Polypektomie tubuläres AdenomJapan
-
Shoichi Fujii, MD, PhDUnbekanntBösartige Neubildung des Colon transversum | Bösartige Neubildung des absteigenden DickdarmsJapan
-
Istituto Clinico HumanitasNuovo Regina Margherita HospitalUnbekanntDarmkrebs | Colon Nos Polypektomie tubuläres Adenom | Gezackte AdenomeItalien
-
Istituto Clinico HumanitasSan Gerardo Hospital; Azienda Ospedaliero Universitaria Maggiore della CaritaAbgeschlossenBlutung | Dickdarmpolypen | Komplikationen | Polyp des Dickdarms | Colon Nos Polypektomie tubuläres AdenomItalien
-
The Second Affiliated Hospital of Chongqing Medical...AbgeschlossenLungenverletzung | Dexmedetomidin | Rektale Tumoren | Chirurgie, Laparoskopie | Tumor des Colon sigmoideumChina
-
Memorial Sloan Kettering Cancer CenterHarvard University; Broad Institute of MIT and HarvardAktiv, nicht rekrutierendLynch-Syndrom | Hereditäre Colon-Polyposis-SyndromeVereinigte Staaten
Klinische Studien zur Laser Speckle Contrast Imaging
-
Medical Centre LeeuwardenUniversity of Groningen; LIMIS DevelopmentRekrutierungLungenkrebsNiederlande
-
Medical Centre LeeuwardenUniversity of Groningen; LIMIS DevelopmentRekrutierung